Q fever

Veterinary Microbiology

Volumn 140, Issue 3-4, 2010, Pages 297-309

  Angelakis, Emmanouil ^a   Raoult, Didier ^a  

^a CNRS   (France)

Author keywords

Coxiella burnetii; Q fever

Indexed keywords

AMIKACIN; AMOXICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GAMMA INTERFERON; HYDROXYCHLOROQUINE; OFLOXACIN; OXYTETRACYCLINE; PEFLOXACIN; Q FEVER VACCINE; Q VAX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROXITHROMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ABORTION; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY TITER; BACTERIAL GENETICS; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL FEATURE; COXIELLA BURNETII; DRUG EFFICACY; DRUG PENETRATION; DRUG TOLERABILITY; ENDOCARDITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HEPATITIS; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; INHALATION; MENINGOENCEPHALITIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PATIENT MONITORING; PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; Q FEVER; RASH; REVIEW; SEROCONVERSION; SERODIAGNOSIS; SEXUAL TRANSMISSION; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; ZOONOSIS;

ANIMALS; ANIMALS, DOMESTIC; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; COXIELLA BURNETII; DISEASE RESERVOIRS; HUMANS; Q FEVER; SEROLOGIC TESTS; TETRACYCLINES; ZOONOSES;

ANIMALIA; COXIELLA BURNETII;

EID: 74249106461     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.07.016     Document Type: Review

References (126)

1. Akporiaye E.T., Rowatt J.D., Aragon A.A., and Baca O.G. Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii. Infect. Immun. 40 (1983) 1155-1162
2. Amano K., Williams J.C., Missler S.R., and Reinhold V.N. Structure and biological relationships of Coxiella burnetii lipopolysaccharides. J. Biol. Chem. 262 (1987) 4740-4747
3. Arricau-Bouvery N., and Rodolakis A. Is Q fever an emerging or re-emerging zoonosis?. Vet. Res. 36 (2005) 327-349
4. Babudieri B. Q fever. A zoonosis. Adv. Vet. Sci. 5 (1959) 82-182
5. Baca O.G., Akporiaye E.T., Aragon A.S., Martinez I.L., Robles M.V., and Warner N.L. Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect. Immun. 33 (1981) 258-266
6. Baca O.G., Scott T.O., Akporiaye E.T., DeBlassie R., and Crissman H.A. Cell cycle distribution patterns and generation times of L929 fibroblast cells persistently infected with Coxiella burnetii. Infect. Immun. 47 (1985) 366-369
7. Banerjee-Bhatnagar N., Bolt C.R., and Williams J.C. Pore-forming activity of Coxiella burnetii outer membrane protein oligomer comprised of 29.5- and 31-kDa polypeptides. Inhibition of porin activity by monoclonal antibodies 4E8 and 4D6. Ann. N.Y. Acad. Sci. 791 (1996) 378-401
8. Benson W.W., Brock D.W., and Mather J. Serologic analysis of a penitentiary group using raw milk from a Q fever infected herd. Public Health Rep. 78 (1963) 707-710
9. Bernit E., Pouget J., Janbon F., Dutronc H., Martinez P., Brouqui P., and Raoult D. Neurological involvement in acute Q fever. A report of 29 cases and review of the literature. Arch. Intern. Med. 162 (2002) 693-700
10. Berri M., Rousset E., Champion J.L., Russo P., and Rodolakis A. Goats may experience reproductive failures and shed Coxiella burnetii at two successive parturitions after a Q fever infection. Res. Vet. Sci. 83 (2007) 47-52
11. Berri M., rricau-Bouvery N., and Rodolakis A. PCR-based detection of Coxiella burnetii from clinical samples. Methods Mol. Biol. 216 (2003) 153-161
12. Botelho-Nevers E., Fournier P.E., Richet H., Fenollar F., Lepidi H., Foucault C., Branchereau A., Piquet P., Maurin M., and Raoult D. Coxiella burnetii infection of aortic aneurysms or vascular grafts. Report of 30 new cases and evaluation of outcome. Eur. J. Clin. Microbiol. Infect. Dis. 26 (2007) 635-640
13. Boulos A., Rolain J.M., Maurin M., and Raoult D. Evaluation of antibiotic susceptibilities against Coxiella burnetii by real time PCR. Int. J. Antimicrob. Agents 23 (2004) 169-174
14. Brennan R.E., and Samuel J.E. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. J. Clin. Microbiol. 41 (2003) 1869-1874
15. Brezina R., Schramek S., and Kazar J. Selection of chlortetracycline-resistant strain of Coxiella burnetii. Acta Virol. 19 (1975) 496
16. Brouqui P., and Raoult D. New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol. Med. Microbiol. 47 (2006) 1-13
17. Burnet F.M., and Freeman M. Experimental studies on the virus of "Q" fever. Med. J. Aust. 2 (1937) 299-305
18. Burton P.R., Stueckemann J., Welsh R.M., and Paretsky D. Some ultrastructural effects of persistent infections by the rickettsia Coxiella burnetii in mouse L cells and green monkey kidney (Vero) cells. Infect. Immun. 21 (1978) 556-566
19. 3 integrin and CR3. J. Immunol. 163 (1999) 6078-6085
20. Capo C., Moynault A., Collette Y., Olive D., Brown E.J., Raoult D., and Mege J.L. Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. J. Immunol. 170 (2003) 4217-4225
21. Carcopino X., Raoult D., Bretelle F., Boubli L., and Stein A. Managing Q fever during pregnancy the benefits of long-term cotrimoxazole therapy. Clin. Infect. Dis. 45 (2007) 548-555
22. Chiu C.K., and Durrheim D.N. A review of the efficacy of human Q fever vaccine registered in Australia. N.S.W. Public Health Bull. 18 (2007) 133-136
23. Derrick E.H. Q fever, a new fever entity clinical features, diagnosis and laboratory investigation. Med. J. Aust. 2 (1937) 281-299
24. Derrick E.H. The course of infection with Coxiella burnetii. Med. J. Aust. 1 (1973) 1051-1057
25. Deutch D.L., and Peterson E.T. Q fever transmission from one human being to others. J. Am. Med. Assoc. 143 (1950) 348-354
26. Dupuis G., Vouilloz M., Peter O., and Mottiez M.C. Incidence of Q fever in Valais. Rev. Med. Suisse Romande 105 (1985) 949-954
27. Editorial, 1950. Editorial: experimental Q fever in man. Br. Med. J. 1, 1000.
28. Fenollar F., Fournier P.E., Carrieri M.P., Habib G., Messana T., and Raoult D. Risks factors and prevention of Q fever endocarditis. Clin. Infect. Dis. 33 (2001) 312-316
29. Fenollar F., Fournier P.E., and Raoult D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J. Clin. Microbiol. 42 (2004) 4919-4924
30. Fenollar F., and Raoult D. Molecular genetic methods for the diagnosis of fastidious microorganisms. APMIS 112 (2004) 785-807
31. Fenollar F., and Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int. J. Antimicrob. Agents 30 Suppl 1 (2007) S7-S15
32. Fishbein D.B., and Raoult D. A cluster of Coxiella burnetti infections associated with exposure to vaccinated goats and their unpasteurized dairy products. Am. J. Trop. Med. Hyg. 47 (1992) 35-40
33. Fournier P.E., Etienne J., Harle J.R., Habib G., and Raoult D. Myocarditis, a rare but severe manifestation of Q fever report of 8 cases and review of the literature. Clin. Infect. Dis. 32 (2001) 1440-1447
34. Fournier P.E., Marrie T.J., and Raoult D. Diagnosis of Q fever. J. Clin. Microbiol. 36 (1998) 1823-1834
35. Gami A.S., Antonios V.S., Thompson R.L., Chaliki H.P., and Ammash N.M. Q fever endocarditis in the United States. Mayo Clin. Proc. 79 (2004) 253-257
36. Gerth H.J., Leidig U., and Riemenschneider T. Q-fieber Epidemie in einem Institut fór Humanpathologie. Deut. Med. Wochenschr. 107 (1982) 1391-1395
37. Ghigo E., Capo C., Tung C.H., Raoult D., Gorvel J.P., and Mege J.L. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation. IFN-gamma mediates its restoration and bacterial killing. J. Immunol. 169 (2002) 4488-4495
38. Ghigo E., Honstettre A., Capo C., Gorvel J.P., Raoult D., and Mege J.L. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J. Infect. Dis. 190 (2004) 1767-1772
39. Gikas A., Kofteridis D.P., Manios A., Pediaditis J., and Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob. Agents Chemother. 45 (2001) 3644-3646
40. Gonder J.C., Kishimoto R.A., Kastello M.D., Pedersen Jr. C.E., and Larson E.W. Cynomolgus monkey model for experimental Q fever infection. J. Infect. Dis. 139 (1979) 191-196
41. Hackstadt T., and Williams J.C. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 3240-3244
42. Harman J.B. Q fever in Great Britain; clinical account of eight cases. Lancet 2 (1949) 1028-1030
43. Hatchette T., Hudson R., Schlech W., Campbell N., Hatchette J., Ratnam S., Donovan C., and Marrie T. Caprine-associated Q fever in Newfoundland. Can. Commun. Dis. Rep. 26 (2000) 17-19
44. Hellenbrand W., Breuer T., and Petersen L. Changing epidemiology of Q fever in Germany, 1947-1999. Emerg. Infect. Dis. 7 (2001) 789-796
45. Honstettre A., Ghigo E., Moynault A., Capo C., Toman R., Akira S., Takeuchi O., Lepidi H., Raoult D., and Mege J.L. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J. Immunol. 172 (2004) 3695-3703
46. Hoover T.A., Vodkin M.H., and Williams J.C. A Coxiella burnetii repeated DNA element resembling a bacterial insertion sequence. J. Bacteriol. 174 (1992) 5540-5548
47. Hotta A., Kawamura M., To H., Andoh M., Yamaguchi T., Fukushi H., and Hirai K. Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies. Infect. Immun. 70 (2002) 4747-4749
48. Houpikian P., Habib G., Mesana T., and Raoult D. Changing clinical presentation of Q fever endocarditis. Clin. Infect. Dis. 34 (2002) E28-E31
49. Huebner R.J., and Bell J.A. Q fever studies in Southern California. Summary of current results and a discussion of possible control measures. J. Am. Med. Assoc. 145 (1951) 301-305
50. Johnson III J.E., and Kadull P.J. Laboratory acquired Q fever. A report of fifty cases. Am. J. Med. 41 (1966) 391-403
51. Karakousis P.C., Trucksis M., and Dumler J.S. Chronic Q fever in the United States. J. Clin. Microbiol. 44 (2006) 2283-2287
52. Kazar J. Q fever. In: Kazar J., and Toman R. (Eds). Rickettsiae and Rickettsial Diseases (1996), Slovak Academy of Sciences, Bratislava 353-362
53. Kelly P.J., Matthewman L.A., Mason P.R., and Raoult D. Q fever in Zimbabwe. S. Afr. Med. J. 83 (1993) 21-25
54. Khalili M., and Sakhaee E. An update on a serologic survey of Q Fever in domestic animals in Iran. Am. J. Trop. Med. Hyg. 80 (2009) 1031-1032
55. Klee S.R., Tyczka J., Ellerbrok H., Franz T., Linke S., Baljer G., and Appel B. Highly sensitive real-time PCR for specific detection and quantification of Coxiella burnetii. BMC Microbiol. 6 (2006) 2
56. Koster F.T., Williams J.C., and Goodwin J.S. Cellular immunity in Q fever. Specific lymphocyte unresponsiveness in Q fever endocarditis. J. Infect. Dis. 152 (1985) 1283-1289
57. Kovacova E., and Kazar J. Q fever-still a query and underestimated infectious disease. Acta Virol. 46 (2002) 193-210
58. Kovacova E., Kazar J., and Spanelova D. Suitability of various Coxiella burnetii antigen preparations for detection of serum antibodies by various tests. Acta Virol. 42 (1998) 365-368
59. Krumbiegel E.R., and Wisniewski H.J. Q fever in Milwaukee. II. Consumption of infected raw milk by human volunteers. Arch. Environ. Health 21 (1970) 63-65
60. Kruszewska D., and Tylewska-Wierzbanowska S. Isolation of Coxiella burnetii from bull semen. Res. Vet. Sci. 62 (1997) 299-300
61. Kruszewska D., and Tylewska-Wierzbanowska S.T. Coxiella burnetii penetration into the reproductive system of male mice, promoting sexual transmission of infection. Infect. Immun. 61 (1993) 4188-4195
62. La Scola B., Lepidi H., and Raoult D. Pathologic changes during acute Q fever. Influence of the route of infection and inoculum size in infected guinea pigs. Infect. Immun. 1 (1997) 2443-2447
63. Landais C., Fenollar F., Thuny F., and Raoult D. From acute Q fever to endocarditis. Serological follow-up strategy. Clin. Infect. Dis. 44 (2007) 1337-1340
64. Lang G.H. Serosurvey of Coxiella burnetii infection in dairy goat herds in Ontario. Can. J. Vet. Res. 52 (1988) 37-41
65. Lang G.H. Coxiellosis (Q fever) in animals. In: Marrie T.J. (Ed). Q Fever, the Disease (1990), CRC Press, Boca Raton 23-48
66. Leone M., Honstettre A., Lepidi H., Capo C., Bayard F., Raoult D., and Mege J.L. Effect of sex on Coxiella burnetii infection. Protective role of 17beta-estradiol. J. Infect. Dis. 189 (2004) 339-345
67. Lepidi H., Coulibaly B., Casalta J.P., and Raoult D. Autoimmunohistochemistry. A new method for the histologic diagnosis of infective endocarditis. J. Infect. Dis. 193 (2006) 1711-1717
68. Lipton J.H., Fong T.C., Gill M.J., Burgess K., and Elliott P.D. Q fever inflammatory pseudotumor of the lung. Chest 92 (1987) 756-757
69. Lohuis P.J.F.M., Ligtenberg P.C., Dieperslost R.J.A., and de Graaf M. Q fever in a patient with a ventriculo-peritoneal drain. Case report and short review of the literature. Netherlands J. Med. 44 (1994) 60-64
70. Mallavia L.P. Genetics of Rickettsiae. Eur. J. Epidemiol. 7 (1991) 213-221
71. Maltezou H.C., and Raoult D. Q fever in children. Lancet Infect. Dis. 2 (2002) 686-691
72. Mantovani A., and Benazzi P. The isolation of Coxiella burnetii from Rhipicephalus sanguineus on naturally infected dogs. J. Am. Vet. Med. Assoc. 122 (1953) 117-118
73. Marmion B.P., Stoker M.G.P., Walker C.B.V., and Carpenter R.G. Q fever in Great Britain-epidemiological information from a serological survey of healthy adults in Kent ans East Anglia. J. Hyg. 54 (1956) 118-140
74. Marrero M., and Raoult D. Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am. J. Trop. Med. Hyg. 40 (1989) 197-199
75. Marrie T.J. Q fever in pregnancy. Report of two cases. Infect. Dis. Clin. Pract. 2 (1993) 207-209
76. Marrie, T.J., 2007. Epidemiology of Q fever. Rickettsial diseases. 281-289.
77. Marrie T.J., Langille D., Papukna V., and Yates L. Truckin pneumonia-an outbreak of Q fever in a truck repair plant probably due to aerosols from clothing contaminated by contact with newborn kittens. Epidemiol. Infect. 102 (1989) 119-127
78. Marrie T.J., and Raoult D. Update on Q fever, including Q fever endocarditis. Curr. Clin. Top. Infect. Dis. 22 (2002) 97-124
79. Marrie T.J., Stein A., Janigan D., and Raoult D. Route of infection determines the clinical manifestations of acute Q fever. J. Infect. Dis. 173 (1996) 484-487
80. Marrie T. Liver involvement in acute Q fever. Chest 94 (1988) 896-898
81. Maurin M., Benoliel A.M., Bongrand P., and Raoult D. Phagolysosomal alkalinization an the bactericidal effect of antibiotics. The Coxiella burnetii paradigm. J. Infect. Dis. 166 (1992) 1097-1102
82. Maurin M., and Raoult D. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents Chemother. 37 (1993) 2633-2637
83. Maurin M., and Raoult D. Q fever. Clin. Microbiol. Rev. 12 (1999) 518-553
84. McDade J.E. Historical aspects of Q fever. In: Marrie T.J. (Ed). Q fever. Volume I. The Disease (1990), CRC Press, Boston 5-21
85. McQuiston J.H., and Childs J.E. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2 (2002) 179-191
86. Meconi S., Capo C., Remacle-Bonnet M., Pommier G., Raoult D., and Mege J.L. Activation of protein tyrosine kinases by Coxiella burnetii. Role in actin cytoskeleton reorganization and bacterial phagocytosis. Infect. Immun. 69 (2001) 2520-2526
87. Meconi S., Jacomo V., Boquet P., Raoult D., Mege J.L., and Capo C. Coxiella burnetii induces reorganization of the actin cytoskeleton in human monocytes. Infect. Immun. 66 (1998) 5527-5533
88. Mege, J.L., 2007. Immune Response to Q fever. Rickettsial Diseases. 271-281.
89. Mertens, K., Samuel, J.E., 2007. Bacteriology of Coxiella: Rickettsial diseases. 257-270.
90. Milazzo A., Hall R., Storm P.A., Harris R.J., Winslow W., and Marmion B.P. Sexually transmitted Q fever. Clin. Infect. Dis. 33 (2001) 399-402
91. Musso D., Drancourt M., Osscini S., and Raoult D. Sequence of the quinolone resistance-determining region of the GYRA gene for clinical isolates and for a stepwise-selected quinolone resistant of Coxiella burnetii. Antimicrob. Agents Chemother. 40 (1996) 870-873
92. Nourse C., Allworth A., Jones A., Horvath R., McCormack J., Bartlett J., Hayes D., and Robson J.M. Three cases of Q fever osteomyelitis in children and a review of the literature. Clin. Infect. Dis. 39 (2004) e61-e66
93. Philip C.B. Comments on the name of the Q fever organism. Public Health Rep. 63 (1948) 58-59
94. Psaroulaki A., Hadjichristodoulou C., Loukaides F., Soteriades E., Konstantinidis A., Papastergiou P., Ioannidou M.C., and Tselentis Y. Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system. Eur. J. Clin. Microbiol. Infect. Dis. 25 (2006) 576-586
95. Raoult D. Treatment of Q fever. Antimicrob. Agents Chemother. 37 (1993) 1733-1736
96. Raoult D., Drancourt M., and Vestris G. Bactericidal effect of Doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob. Agents Chemother. 34 (1990) 1512-1514
97. Raoult D., Etienne J., Massip P., Iaocono S., Prince M.A., Beaurain P., Benichou S., Auvergnat J.C., Mathieu P., and Bachet P. Q fever endocarditis in the south of France. J. Infect. Dis. 155 (1987) 570-573
98. Raoult D., Fenollar F., and Stein A. Q fever during pregnancy. Diagnosis, treatment, and follow-up. Arch. Intern. Med. 162 (2002) 701-704
99. Raoult D., Houpikian P., Tissot Dupont H., Riss J.M., Arditi-Djiane J., and Brouqui P. Treatment of Q fever endocarditis: comparison of two regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Int. Med. 159 (1999) 167-173
100. Raoult D., Laurent J.C., and Mutillod M. Monoclonal antibodies to Coxiella burnetii for antigenic detection in cell cultures and in paraffin embedded tissues. Am. J. Clin. Pathol. 101 (1994) 318-320
101. Raoult D., Levy P.Y., Harle J.R., Etienne J., Massip P., Goldstein F., Micoud M., Beytout J., Gallais H., Remy G., and Capron J.P. Chronic Q fever. Diagnosis and follow up. Ann. N.Y. Acad. Sci. 590 (1990) 51-60
102. Raoult D., Marrie T., and Mege J. Natural history and pathophysiology of Q fever. Lancet Infect. Dis. 5 (2005) 219-226
103. Raoult D., Tissot-Dupont H., Foucault C., Gouvernet J., Fournier P.E., Bernit E., Stein A., Nesri M., Harle J.R., and Weiller P.J. Q fever 1985-1998-clinical and epidemiologic features of 1383 infections. Medicine 79 (2000) 109-123
104. Raoult D., Torres H., and Drancourt M. Shell-vial assay. Evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 35 (1991) 2070-2077
105. Rolain, J.M., 2007. Antimicrobial susceptibility of Rickettsial agents: Rickettsial diseases. 361-369.
106. Rolain J.M., Boulos A., Mallet M.N., and Raoult D. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Antimicrob. Agents Chemother. 49 (2005) 2673-2676
107. Rolain J.M., Lambert F., and Raoult D. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline. Ann. N.Y. Acad. Sci. 1063 (2005) 252-256
108. Rolain J.M., Mallet M.N., and Raoult D. Correlation between serum levels of doxycycline and serology evolution in patients treated for Coxiella burnetii endocarditis. J. Infect. Dis. 9 (2003) 1322-1325
109. Roman M.J., Coriz P.D., and Baca O.G. A proposed model to explain persistent infection of host cells with Coxiella burnetii. J. Gen. Microbiol. 132 (1986) 1415-1422
110. + T-cell lymphopenia in Q fever endocarditis. Clin. Diag. Lab. Immunol. 4 (1997) 89-92
111. Sanford E.S., Josephson G.K.A., and MacDonald A. Coxiella burnetii (Q fever) abortion storms in goat herds after attendance at an annual fair. Can. Vet. J. 35 (1994) 376-378
112. Seshadri R., Paulsen I.T., Eisen J.A., Read T.D., Nelson K.E., Nelson W.C., Ward N.L., Tettelin H., Davidsen T.M., Beanan M.J., Deboy R.T., Daugherty S.C., Brinkac L.M., Madupu R., Dodson R.J., Khouri H.M., Lee K.H., Carty H.A., Scanlan D., Heinzen R.A., Thompson H.A., Samuel J.E., Fraser C.M., and Heidelberg J.F. Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5455-5460
113. Shannon J.G., Howe D., and Heinzen R.A. Virulent Coxiella burnetii does not activate human dendritic cells. Role of lipopolysaccharide as a shielding molecule. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8722-8727
114. Siegman-Igra Y., Kaufman O., Keysary A., Rzotkiewicz S., and Shalit I. Q fever endocarditis in Israel and a worldwide review. Scand. J. Infect. Dis. 29 (1997) 41-49
115. Stein A., and Raoult D. Pigeon pneumonia in Provence. A bird borne Q fever outbreak. Clin. Infect. Dis. 29 (1999) 617-620
116. Stoker, M.G., Marmion, B.P., 1995. The spread of Q fever from animals to man. The natural history of a rickettsial disease. Bull WHO781-806.
117. Tiggert W.D., and Benenson A.S. Studies on Q fever in man. Trans. Assoc. Am. Phys. 69 (1956) 98-104
118. Tissot-Dupont, H., Raoult, D., 2007. Clinical aspects, diagnosis and treatment of Q fever: Rickettsial diseases. 291-301.
119. Tissot-Dupont H., Raoult D., Brouqui P., Janbon F., Peyramond D., Weiller P.J., Chicheportiche C., Nezri M., and Poirier R. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients, 323 French cases. Am. J. Med. 93 (1992) 427-434
120. Torres H., and Raoult D. In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii. Determined using the shell Vial Assay. Antimicrob. Agents Chemother. 37 (1993) 491-494
121. Vodkin M.H., and Williams J.C. Overlapping deletion in two spontaneous phase variants of Coxiella burnetii. J. Gen. Microbiol. 132 (1986) 2587-2594
122. Webster J.P., LLoyd G., and Macdonald D.W. Q fever (Coxiella burnetii) reservoir in wild brown rat (Rattus norvegicus) populations in the UK Wildlife conservation Research Unit, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS - centre for Applied Microbiology and research, Division of Pathology, Porton Down, Salisbury, Wiltshire SP4 OJG. Parasitology 110 (1995) 31-35
123. Yeaman M.R., and Baca O.G. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii. Ann. N.Y. Acad. Sci. 590 (1990) 297-305
124. Yeaman M.R., Mitscher L.A., and Baca O.G. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 31 (1987) 1079-1084
125. Yeaman M.R., Roman M.J., and Baca O.G. Antibiotic susceptibilities of two Coxiella burnetii isolates implicate in distinct clinical syndromes. Antimicrob. Agents Chemother. 33 (1989) 1052-1057
126. Zamboni D.S., Campos M.A., Torrecilhas A.C., Kiss K., Samuel J.E., Golenbock D.T., Lauw F.N., Roy C.R., Almeida I.C., and Gazzinelli R.T. Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection. J. Biol. Chem. 279 (2004) 54405-54415